Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | MGAM | O43451 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | SI | P14410 | 1/20 | 0.42 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 5/20 | 0.38 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.35 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.35 |
| ▸ | HTR1A | P08908 | 1/20 | 0.35 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methacrylic Acid SCHEMBL2585573 | 1.00 | ALOX15 (0.68) | ALOX15ALDH1A1LMNAHSD17B10MGAM | |
| Methacrylic Acid SCHEMBL403852 | 1.00 | ALOX15 (0.68) | ALOX15ALDH1A1LMNAHSD17B10MGAM | |
| Methacrylic Acid SCHEMBL15563 | 1.00 | ALOX15 (0.68) | ALOX15ALDH1A1LMNAHSD17B10MGAM | |
| Methacrylic Acid SCHEMBL29579615 | 1.00 | ALOX15 (0.68) | ALOX15ALDH1A1LMNAHSD17B10MGAM | |
| Methacrylic Acid SCHEMBL2062627 | 1.00 | ALOX15 (0.68) | ALOX15ALDH1A1LMNAHSD17B10MGAM | |
| Methacrylic Acid SCHEMBL9903977 | 1.00 | ALOX15 (0.68) | ALOX15ALDH1A1LMNAHSD17B10MGAM | |
| Methacrylic Acid SCHEMBL709886 | 1.00 | ALOX15 (0.68) | ALOX15ALDH1A1LMNAHSD17B10MGAM | |
| Methacrylic Acid SCHEMBL29580156 | 1.00 | ALOX15 (0.68) | ALOX15ALDH1A1LMNAHSD17B10MGAM | |
| Methacrylic Acid SCHEMBL31087603 | 1.00 | ALOX15 (0.68) | ALOX15ALDH1A1LMNAHSD17B10MGAM | |
| Methacrylic Acid SCHEMBL5873332 | 1.00 | ALOX15 (0.68) | ALOX15ALDH1A1LMNAHSD17B10MGAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12428518-B2 | (Meth)acrylate-functionalized extended isosorbide | HENKEL AG & CO. KGAA (DE) | 2025-09-30 | — | — | US | claimed |
| US-11691034-B2 | Methods for strengthening and repairing nails using curable compositions | FAMOUS NAMES, LLC (US) | 2023-07-04 | — | — | US | claimed |
| US-12428518-B2 | (Meth)acrylate-functionalized extended isosorbide | HENKEL AG & CO. KGAA (DE) | 2025-09-30 | — | — | US | disclosed |
| US-12138843-B2 | Extruded hydrogel tubes and coaxial fibers and applications thereof | UNIVERSITY OF WASHINGTON (US) | 2024-11-12 | — | — | US | disclosed |
| US-20240358417-A1 | METHOD OF CREATING BIOCOMPATIBLE POLYMERIC RESIN SYSTEMS FOR BONE REPAIR AND MANAGEMENT | MediCarbone, Inc. | 2024-10-31 | — | — | US | disclosed |
| EP-2969018-B1 | CURABLE NAIL COMPOSITION AND METHODS FOR STRENGTHENING AND REPAIRING NAILS | FAMOUS NAMES LLC (US) | 2024-07-31 | — | — | EP | disclosed |
| US-11925401-B1 | Method of creating biocompatible polymeric resin systems for bone repair and management | MediCarbone, Inc. (US) | 2024-03-12 | — | — | US | disclosed |
| US-20240074791-A1 | SYSTEMS AND METHODS FOR BONE REPAIR AND MANAGEMENT USING BIOCOMPATIBLE POLYMERIC RESIN | MediCarbone, Inc. | 2024-03-07 | — | — | US | disclosed |
| WO-2024050507-A2 | SYSTEMS AND METHODS FOR BONE REPAIR AND MANAGEMENT USING BIOCOMPATIBLE POLYMERIC RESIN | MediCarbone, Inc. (US) | 2024-03-07 | — | — | WO | disclosed |
| US-20230303747-A1 | CURABLE COMPOSITION, STORAGE CONTAINER, AND THREE-DIMENSIONAL OBJECT PRODUCING METHOD | RICOH COMPANY, LTD. (JP) | 2023-09-28 | — | — | US | disclosed |
| EP-4248935-A1 | CURABLE COMPOSITION, STORAGE CONTAINER, AND THREE-DIMENSIONAL OBJECT PRODUCING METHOD | Ricoh Company, Ltd. (JP) | 2023-09-27 | — | — | EP | disclosed |
| US-11718580-B2 | Fluorene derivatized monomers and polymers for volume Bragg gratings | META PLATFORMS TECHNOLOGIES, LLC (US) | 2023-08-08 | — | — | US | disclosed |
| EP-3966195-B1 | FLUORENE DERIVATIZED MONOMERS AND POLYMERS FOR VOLUME BRAGG GRATINGS | FACEBOOK TECH LLC (US) | 2023-07-05 | — | — | EP | disclosed |
| US-11691034-B2 | Methods for strengthening and repairing nails using curable compositions | FAMOUS NAMES, LLC (US) | 2023-07-04 | — | — | US | disclosed |
| CN-114409668-A | Isosorbide derivative and pit and furrow closing agent based on isosorbide structure | 上海交通大学医学院附属第九人民医院 | 2022-04-29 | — | — | CN | disclosed |
| EP-3966195-A1 | FLUORENE DERIVATIZED MONOMERS AND POLYMERS FOR VOLUME BRAGG GRATINGS | Facebook Technologies, LLC (US) | 2022-03-16 | — | — | EP | disclosed |
| EP-2621713-A1 | DEVICE AND METHOD FOR THE PRODUCTION OF 3D STRUCTURES IN LAYERS, AND USE THEREOF | Fraunhofer Gesellschaft zur Förderung der angewandten Wissenschaft E.V. (DE) | 2013-08-07 | — | — | EP | disclosed |
| WO-2012041522-A1 | DEVICE AND METHOD FOR THE PRODUCTION OF 3D STRUCTURES IN LAYERS, AND USE THEREOF | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2012-04-05 | — | — | WO | disclosed |
| US-5690869-A | Use of a polymer material on the basis of modified hydrocolloids as covering material | OMNITECHNIK (DE) | 1997-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12428518-B2 | (Meth)acrylate-functionalized extended isosorbide | MGMT, ALKBH2, INSR | ALOX15 4119/4885ALDH1A1 58/4885LMNA 4540/4885 |
| US-20230303747-A1 | CURABLE COMPOSITION, STORAGE CONTAINER, AND THREE-DIMENSIONAL OBJECT PRODUCING METHOD | MMAB, ALG3, UFM1 | ALOX15 1639/4885ALDH1A1 492/4885LMNA 1634/4885 |
| US-11718580-B2 | Fluorene derivatized monomers and polymers for volume Bragg gratings | RHOA, PARG, LSG1 | ALOX15 1789/4885ALDH1A1 2248/4885LMNA 1160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.